38 research outputs found
Weak discrete maximum principles
summary:We introduce weak discrete maximum principles for matrix equations associated with some elliptic problems. We also give an example on discrete maximum principles
Evaluation of Injury Severity for Pedestrian VehicleCrashes in Jordan Using Extracted Rules
[EN] Pedestrian safety is a major concern throughout the world because pedestrians are considered to be the most vulnerable roadway
users. This paper sought to identify the main factors in pedestrian-vehicle crashes that increase the risk of a fatality or severe injury.
Pedestrian-vehicle crashes which occurred in urban and suburban areas in Jordan between 2009 and 2011 were investigated. Extracted rules
from Bayesian networks were used to identify factors related to severity of pedestrian-vehicle crashes. To obtain as much information as
possible about these factors, three subsets were used. The first and second subsets contain all types of collisions (pedestrian and nonpedestrian), in which the first subset used collision type as a class variable and the second subset used injury severity. The third subset contains
pedestrian collisions only and used injury severity as the class variable. The results indicate that when using collision type as the class
variable, better performance was obtained and that the following variables increase the risk of fatality or severe injury: roadway type, number
of lanes, speed limit, lighting, and adverse weather conditions.Mujalli, R.; Garach, L.; LĂłpez-Maldonado, G.; Al-Rousan, T. (2019). Evaluation of Injury Severity for Pedestrian VehicleCrashes in Jordan Using Extracted Rules. Journal of Transportation Engineering. 145(7):04019028-1-04019028-13. https://doi.org/10.1061/JTEPBS.0000244S04019028-104019028-13145
Bioinformatics insights into the genes and pathways on severe COVID-19 pathology in patients with comorbidities
Background: Coronavirus disease (COVID-19) infection is known for its severe clinical pathogenesis among individuals with pre-existing comorbidities. However, the molecular basis of this observation remains elusive. Thus, this study aimed to map key genes and pathway alterations in patients with COVID-19 and comorbidities using robust systems biology approaches.Methods: The publicly available genome-wide transcriptomic datasets from 120 COVID-19 patients, 281 patients suffering from different comorbidities (like cardiovascular diseases, atherosclerosis, diabetes, and obesity), and 252 patients with different infectious diseases of the lung (respiratory syncytial virus, influenza, and MERS) were studied using a range of systems biology approaches like differential gene expression, gene ontology (GO), pathway enrichment, functional similarity, mouse phenotypic analysis and drug target identification.Results: By cross-mapping the differentially expressed genes (DEGs) across different datasets, we mapped 274 shared genes to severe symptoms of COVID-19 patients or with comorbidities alone. GO terms and functional pathway analysis highlighted genes in dysregulated pathways of immune response, interleukin signaling, FCGR activation, regulation of cytokines, chemokines secretion, and leukocyte migration. Using network topology parameters, phenotype associations, and functional similarity analysis with ACE2 and TMPRSS2âtwo key receptors for this virus-we identified 17 genes with high connectivity (CXCL10, IDO1, LEPR, MME, PTAFR, PTGS2, MAOB, PDE4B, PLA2G2A, COL5A1, ICAM1, SERPINE1, ABCB1, IL1R1, ITGAL, NCAM1 and PRKD1) potentially contributing to the clinical severity of COVID-19 infection in patients with comorbidities. These genes are predicted to be tractable and/or with many existing approved inhibitors, modulators, and enzymes as drugs.Conclusion: By systemic implementation of computational methods, this study identified potential candidate genes and pathways likely to confer disease severity in COVID-19 patients with pre-existing comorbidities. Our findings pave the way to develop targeted repurposed therapies in COVID-19 patients
Improving influenza vaccination rate among primary healthcareworkers in Qatar
The purpose of this study was to improve influenza vaccination, and determine factors influencing vaccine declination among health care workers (HCW) in Qatar. We launched an influenza vaccination campaign to vaccinate around 4700 HCW in 22 Primary Health Care Corporation (PHCC) centers in Qatar between 1st and 15th of November, 2015. Our target was to vaccinate 60% of all HCW. Vaccine was offered free of charge at all centers, and information about the campaign and the importance of influenza vaccination was provided to employees through direct communication, emails, and social media networks. Staff were reported as vaccinated or non-vaccinated using a declination form that included their occupation, place of work and reasons for declining the vaccine. Survey responses were summarized as proportional outcomes. We exceeded our goal, and vaccinated 77% of the target population. Only 9% declined to take the vaccine, and the remaining 14% were either on leave or had already been vaccinated. Vaccine uptake was highest among aides (98.1%), followed by technicians (95.2%), and was lowest amongst pharmacists (73.2%), preceded by physicians (84%). Of those that declined the vaccine, 34% provided no reason, 18% declined it due to behavioral issues, and 21% declined it due to medical reasons. Uptake of influenza vaccine significantly increased during the 2015 immunization campaign. This is attributed to good planning, preparation, a high level of communication, and providing awareness and training to HCW with proper supervision and monitoring. 1 2017 by the authors. Licensee MDPI, Basel, Switzerland.Acknowledgments: We would like to thank all staff for participation in the 2015 influenza vaccination campaign at the PHCC. Members of the Health protection at MoPH and PHCC communicable disease control team are highly acknowledged for assistance with implementation. This Study was funded by the Ministry of Public Health.Scopu
ANTIPSYCHOTICS- CLASSIFICATION, USES, AND ADVERSE EFFECTS
Introduction: Antipsychotic agents are categorized usually as either âtypical antipsychoticsâ or âatypical antipsychoticsâ. Typical antipsychotic pharmacological agents, which are also called first-generation antipsychotics or traditional antipsychotics, include chlorpromazine and haloperidol. On the other hand, atypical antipsychotic pharmacological agents, which are also called second generation antipsychotics, include risperidone, quetiapine, and olanzapine. Both typical and atypical antipsychotics work in similar mechanisms by inhibiting the activation of specific receptors in the dopamine pathway.Aim of work: In this review, we will discuss the antipsychotics- classification, uses, and adverse effects, Methodology: We did a systematic search for antipsychotics- classification, uses, and adverse effects using PubMed search engine (http://www.ncbi.nlm.nih.gov/) and Google Scholar search engine (https://scholar.google.com). All relevant studies were retrieved and discussed. We only included full articles.Conclusions: The prescription of atypical antipsychotic agents, like quetiapine and olanzapine, has been significantly increasing and in many conditions, they are sometimes prescribed âoff-labelâ â which is a worrying trend due to their possible risk of developing harmful adverse events. Therefore, atypical antipsychotic agents must only be used in their specific indications and with caution, especially among older patients and young adults. Atypical antipsychotic agents can be indicated for schizophrenia treatment and other associated conditions and in some cases to treat the behavioral and psychological manifestations related to dementia (risperidone only). Antipsychotics are not first-line treatments for patients with anxiety and are not generally recommended for the use in patients with posttraumatic stress disorder or insomnia.
Key words: antipsychotics, classification, uses, and adverse effects
Recommended from our members
Sleep quality is associated with vitamin B12 status in female Arab students
Studies have explored how vitamin B12 status affects sleep among elders and children, but this remains to be investigated among young adults. We used the Pittsburgh Sleep Quality Index (PSQI) to assess the association between serum vitamin B12 and sleep among female college students in Saudi Arabia. In this cross-sectional study, we enrolled 355 participants (age (years), 20.7 ± 1.5; body mass index, 23.6 kg/m2 ± 5.2) at King Saud University, Riyadh, Saudi Arabia. Fasting blood samples were analyzed regarding the serum vitamin B12 and blood lipids. Anthropometric, socio-demographic, clinical history, stress, physical activity, and dietary data were collected. We assessed the sleep statuses of the participants using the PSQI. Around 72% of the participants were âpoorâ sleepers (PSQI > 5). Subgroup analysis within the tertiles showed that participants with higher vitamin B12 in the second and third tertiles reported better scores for sleep quality (B ± SE = â12.7 ± 5.6, p = 0.03; B ± SE = â32.7 ± 16.4, p = 0.05, respectively) and also reported a lower use of sleep medication (B ± SE = â21.2 ± 9.9, p = 0.03, in the second tertile only), after adjusting for the waistâhip ratio and stress. However, sleep was not found to be directly associated with either serum vitamin B12 or dietary vitamin B12. In conclusion, the serum vitamin B12 results show that the participants with higher vitamin B12 in the second and third tertiles reported better scores on the sleep quality scale and a lower use of sleep medication. However, no such associations were observed with the overall PSQI. More studies with larger sample sizes are needed to establish a direct relationship between sleep and vitamin B12
Antibody Response to SARS-CoV-2: A Cohort Study in Qatar's Primary Care Settings.
Globally, countries are rolling out Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) quarantine policies and vaccination programs. Research studies are needed in helping understand the likelihood of acquired immunity to reinfection and identify priority groups for vaccination to inform them. This study aimed to assess period prevalence and longitudinal changes in antibody levels after SARS-CoV-2 infection in Qatari primary care settings. A cohort study design with 2 data collection phases was undertaken-Phase 1 (conducted in July 2020) and Phase 2 (conducted in October 2020). A stratified random sampling technique by age, gender and nationality was utilized to identify the study sample. The total sample size required for the study was estimated to be 2102. Participants were invited to an appointment where they were administered a questionnaire and provided samples for polymerase chain reaction and Immunoglobulin G immunoassay tests. A total of 943 individuals participated in both Phase 1 and Phase 2. In this cohort, seroprevalence of SARS-CoV-2 was found to be 12% (Nâ=â113) in Phase 1 and 17.2% (Nâ=â162) in Phase 2. Of the 113 participants who were seropositive in Phase 1, 38.1% (CI 29.5-47.2%, Nâ=â43) had a reduction, 54.9% (CI 45.7-63.8%, Nâ=â62) had no change, and 7.1% (CI 3.4-12.9%, Nâ=â8) had an increase in IgG titer in Phase 2. All (Nâ=â18) participants aged 10 to 17âyears retained their antibodies. The proportion of men who retained their antibodies was slightly higher compared to women-92.5% (Nâ=â74) and 87.9% (Nâ=â29) respectively. Similarly, symptomatic individuals (97.8%; Nâ=â45) had a higher antibody retention compared with asymptomatic individuals (86.4%; Nâ=â57). This study provides preliminary information on the longitudinal changes in antibody levels after SARS-CoV-2 infection. These findings will help inform quarantine policies and vaccination programs.The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by PHCC (PHCCDCR202005047).The funders had no role in the design, analysis, interpretation, or writing
Some maximum principles for solutions of a class of partial differential equations in Ωâân
We find maximum principles for solutions of semilinear elliptic
partial differential equations of the forms: (1) Î2u+αf(u)=0, αââ+ and (2) ÎÎu+α(Îu)k+gu=0, αâ€0 in some region
Ωâân